leisure time -WSS

leisure time

author：focus 2025-09-06 03:55:33 - browse：3

A woman uses her phone to scan a barcode. -- Health coverage from STAT — A Color Health service promises to make it easier to get cancer screenings. Color Health

Color Health wants to take away any reason you might have for skipping screenings for cancer.

The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get the appropriate screenings, whether at a clinic or at home.

“If we can take away all your excuses for not doing the prevention, can we get you to do the prevention,” said Alicia Zhou, the company’s chief scientific officer. “It’s bringing the care to the patient, instead of bringing the patient to care.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Why hospitals are withdrawing from US News rankings

knowledge

WSS

Cosmetics set for new safety regulation. Why the industry is on board

Physician groups backed by private equity giant lobby on mergers

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Startup Neumora takes a novel depression drug to Phase 3

FDA approves RSV monoclonal antibody for infants, toddlers

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

focus

leisure time

knowledge

Hollywood unions extend contract negotiations for actors

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Duchenne breakthrough therapy leaves behind pioneering families

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Drug repurposing or repositioning? The language matters

New safety details link Apellis eye drug to rare cases of blindness

BioMarin wins approval for gene therapy to treat hemophilia A

At Orexo, a ‘turning point’ for everything but digital health

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New safety details link Apellis eye drug to rare cases of blindness

focus

Physician groups backed by private equity giant lobby on mergers

At Orexo, a ‘turning point’ for everything but digital health

EQRx, failed developer of low

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Lawsuit alleges UnitedHealth Group unit illegally denied claims

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

leisure time

hotspot

knowledge

hotspot